- Home
- CCEL vs RGS Comparison
CCEL vs RGS Comparison
Compare CCEL & RGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CCEL | RGS |
|---|---|---|
| Founded | 1989 | 1922 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Managed Health Care | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.8M | 72.6M |
| IPO Year | 2022 | 1994 |
Fundamental Metrics
Financial Performance| Metric | CCEL | RGS |
|---|---|---|
| Price | $5.40 | $23.40 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 7.6K | ★ 13.9K |
| Earning Date | 10-09-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.23 | 0.18 |
| Revenue | $25,384,279.00 | ★ $224,485,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.68 |
| P/E Ratio | ★ $23.43 | $129.72 |
| Revenue Growth | ★ 9.76 | 6.83 |
| 52 Week Low | $2.72 | $19.31 |
| 52 Week High | $5.45 | $32.00 |
Technical Indicators
Market Signals| Indicator | CCEL | RGS |
|---|---|---|
| Relative Strength Index (RSI) | 51.48 | 28.59 |
| Support Level | $3.05 | $21.19 |
| Resistance Level | $5.45 | $23.27 |
| Average True Range (ATR) | 0.34 | 1.31 |
| MACD | -0.02 | -0.67 |
| Stochastic Oscillator | 48.21 | 4.77 |
Price Performance
Historical ComparisonAbout CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
About RGS Regis Corporation
Regis Corporation franchises, owns, and operates hair care salons, mainly in North America, with licensed locations in the U.K. Its salons provide haircutting, styling, shampooing and conditioning, hair coloring and related services, and also sell hair care and beauty products. The company's primary brands include Supercuts, SmartStyle, Cost Cutters, First Choice Haircutters and Roosters. Its operating segments are Franchise and Company-Owned, with the majority of its revenue generated from the Franchise segment.